Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone Anti-proteinuric Effects in Type 2 Diabetes
NCT00749047Phase 4Unknown
- Sponsor
- Christchurch Hospital
- Start
- Sep 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Christchurch Hospital. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00749047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749047.